Study genetics behind blood disorders in children and families
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (the main participant) are being treated or getting expert advice for a blood disorder that is not cancer (non-malignant) or for MDS or MPN
- You may join as the main participant or as a family member of the main participant
- You must be biologically related to the main participant
- Eligible relatives include first-, second-, or third-degree family members (close family)
- There are no listed exclusion criteria for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what leads to specific blood cancers and related blood disorders. If you have one of the listed conditions (or are being evaluated for it), you may be asked to join research that helps doctors understand why these illnesses happen.
This study looks at two childhood blood disorders—myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML). The goal is to describe how these conditions work in children and better understand them over time.
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This study looks at why people with inherited bone marrow failure syndromes (rare genetic conditions affecting blood cell production) have higher cancer risk. Researchers want to understand the genetic and medical factors that increase cancer likelihood, which could help doctors monitor and protect affected patients and their families.
This study collects and stores blood and bone marrow samples from young people with certain blood cancers so doctors can do genetic (“genomic”) testing now and in the future. It may help improve understanding of the disease and support better matching of care for patients.
Hear when a new Hemostasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.